SCHEMBL23997213

SCHEMBL23997213

CNc1ccccc1N(C=O)Cc1ccc2c(c1)SCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23997262 0.70 MAPT (0.43) —
SCHEMBL23997412 0.69 L3MBTL1 (0.49) —
SCHEMBL23997165 0.68 KMT2A (0.41) —
SCHEMBL12694254 0.67 CTSL (0.43) —
SCHEMBL29274137 0.66 ALDH1A1 (0.33) —
SCHEMBL23997321 0.66 — —
SCHEMBL24197472 0.65 TAAR1 (0.47) —
SCHEMBL10388342 0.65 CNR1 (0.39) —
SCHEMBL24197475 0.63 SIGMAR1 (0.45) —
SCHEMBL24197466 0.63 HTR1B (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021226003-A1 IL4I1 INHIBITORS AND METHODS OF USE MERCK SHARP & DOHME CORP. (US) 2021-11-11 — — WO disclosed
Send feedback